HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Times Sure Are a-Changin’: Revlon Announces ‘EWG Verified’ Launch

Executive Summary

Revlon’s new PhotoReady Prime Plus Primers include a Perfecting + Smoothing variant boasting the “EWG Verified” seal. Meanwhile, P&G’s Herbal Essences has extended its own use of EWG credentials. The developments signal increasing industry openness to partnering with a longtime rival in the interest of bolstering confidence and winning fresh business in today’s hazard-averse consumer climate.

You may also be interested in...



Is ‘Skin Deep’ Group Out Of Its Depth? EWG Announces ‘Verified’ Expansion To Cosmetic Ingredients

The Environmental Working Group is probing deeper in the supply chain to enhance its understanding of the cosmetics industry and ingredient safety underpinnings. EWG president Ken Cook and Kali Rauhe, director of cosmetic science, discuss the group’s plans for ingredient verification and greater scientific collaboration with cosmetics companies.

Revlon In COVID-19 Tailspin; E-Commerce, At-Home Beauty Provide Lifts

At-home nail and hair care and e-commerce were bright spots in a numbing second quarter for Revlon, which was hit hard by mass retail and salon channel closures at a time of ongoing transformation.

Environmental Working Group Awards Its ‘Verified’ Seal To First CBD Brand, Prima

The “EWG VERIFIED” mark, and Prima’s recently earned B Corp certification, should help to bolster the company’s purpose-driven, “beyond clean” claims in consumers’ esteem. At a time of regulatory uncertainty, mounting litigation and outstanding safety questions, distinguishing one’s CBD brand from bad actors and mere opportunists increasingly is the name of the game.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149655

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel